Packaging & Labelling
With its cargo operations, Turkish Cargo maintains the air bridge built by Turkish Airlines
As the global repercussions of the unprecedented situation caused by COVID-19 outbreak continues, Turkish Cargo, the global brand with the world’s sixth largest cargo capacity, has started to operate cargo flights with Turkish Airlines’ passenger aircrafts in addition to...
Press Releases
Ufovax successfully extended its Nanoparticle vaccine technology to SARS-CoV-2
Ufovax, a spin-off vaccine company from Scripps Research, announced that the company has successfully extended its patented one component self-assembling protein nanoparticle (1c-SApNP) vaccine platform technology to a vaccine against the coronavirus SARS-CoV-2. The vaccine prototype features SARS-CoV-2 protein...
Drug Research
Univercells launches cell & gene therapy CMDO Exothera with GMP capabilities in 15,000m2 site in Jumet, Belgium
Univercells has launched a contract development and manufacturing organization (CDMO), Exothera, to support cell and gene therapy developers with process development and production of viral vectors. The company has been created to help alleviate the two most critical challenges...
Packaging & Labelling
Turkish Cargo, the global air cargo brand, starts its direct flights to Linz, Austria
Enjoying the widest direct cargo flight network of the worldamong the global air cargo carriers, Turkish Cargo continues to increase the number of destinations with direct flightswith its freighters.
Having an attractive location from the viewpoint of the logistics and...
Clinical Trials
CluePoints Central Statistical Monitoring Supports Business Continuity as Coronavirus Impacts Clinical Trial Operations
CluePoints, the premier provider of Risk-Based Trial Execution (RBx) and Data Quality Oversight Software for clinical trials, announced that it has seen a dramatic increase in demand for remote and centralized site monitoring amid the ongoing Coronavirus outbreak. With...
Press Releases
Bormioli Pharma issues a binding offer to acquire GCL Pharma Srl
Bormioli Pharma announces the issuing of a Binding Offer for the acquisition of 100% of GCL Pharma, an Italian subsidiary of the Guala Closures Group, specialised in the production of plastic, rubber and aluminium closures for pharmaceutical applications.
In 2019...
Clinical Trials
Zydus and XOMA Announce IL-2-Based Immuno-Oncology Therapy Licensing Agreement
Zydus Cadila, an innovation-driven global pharmaceutical company, and XOMA Corporation announced they have entered into a licensing agreement to advance an IL-2-based immuno-oncology (IO) drug candidate that combines Zydus’ IL-2 with XOMA’s novel anti-IL-2 monoclonal antibody.
As part of the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.